Clinical experience with monoclonal antibodies to epidermal growth factor receptor-Reference-Cited by-同舟云学术

Clinical experience with monoclonal antibodies to epidermal growth factor receptor

Published:2005-04 Issue:2 Volume:7 Page:96-103
ISSN:1523-3790
Container-title:Current Oncology Reports
language:en
Short-container-title:Curr Oncol Rep

Author:

Calvo Emiliano,Rowinsky Eric K.

Publisher

Springer Science and Business Media LLC

Subject

Oncology

Link

http://link.springer.com/content/pdf/10.1007/s11912-005-0034-9.pdf

Reference58 articles.

1. Baselga J: Why the epidermal growth factor receptor? The rationale for cancer therapy. Oncologist 2002, 7(Suppl: 4): 2–8.

2. Rowinsky EK: The erbB family: targets for therapeutic development against cancer and therapeutic strategies using monoclonal antibodies and tyrosine kinase inhibitors. Annu Rev Med 2004, 55: 433–457. An interesting review on EGFR biology and therapeutic strategies targeting it.

3. Rowinsky E: Targeting signal transduction. The erbB receptor family as a target for therapeutic development against cancer. In Signal Transduction Inhibitors. Edited by GA Golden. West Conshohocken, PA: Meniscus Educational Institute; 2001: 3–36.

4. Mendelsohn J: Targeting the epidermal growth factor receptor for cancer therapy. J Clin Oncol 2002, 20: 1S-13S.

5. Baselga J, Albanell J, Molina MA: The ErbB receptor family: a therapeutic target for cancer. Trends Mol Med 2004, 8: S19-S26.

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Review on The Development, Production Strategies, and Utilization of Monoclonal Antibodies;The Journal of Basic and Clinical Health Sciences;2020

2. Expression of Phosphorylated Histone H2AX (γ-H2AX) in Normal and Neoplastic Squamous Epithelia of the Uterine Cervix;International Journal of Gynecological Pathology;2011-01

3. Epidermal growth factor receptor and HER-2/neu status by immunohistochemistry and fluorescence in situ hybridization in adenocarcinomas of the biliary tree and gallbladder;Human Pathology;2010-04

4. EGFR-Directed Monoclonal Antibodies;Macromolecular Anticancer Therapeutics;2009-09-14

5. Combination treatment of Cetuximab and photodynamic therapy in SNU-1041 squamous cancer cell line;Oncology Reports;2009-08-31